169 related articles for article (PubMed ID: 30396640)
41. [Hemodynamic changes in benign and malignant breast tumors and the mechanism].
Li YJ; Yang L; Xia Q; Wen G
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Aug; 29(8):1557-60. PubMed ID: 19726291
[TBL] [Abstract][Full Text] [Related]
42. Pitfalls of Contrast Enhanced Ultrasound (CEUS) in determination of breast tumor biological dignity.
Lehotska V; Rauova K; Vanovcanova L
Neoplasma; 2018; 65(1):124-131. PubMed ID: 29322796
[TBL] [Abstract][Full Text] [Related]
43. Incidentally detected splenic lesions in ultrasound: does contrast-enhanced ultrasonography improve the differentiation of benign hemangioma/hamartoma from malignant lesions?
Stang A; Keles H; Hentschke S; von Seydewitz CU; Dahlke J; Habermann C; Wessling J
Ultraschall Med; 2011 Dec; 32(6):582-92. PubMed ID: 22161555
[TBL] [Abstract][Full Text] [Related]
44. Contrast-enhanced ultrasound using real-time contrast harmonic imaging in invasive breast cancer: comparison of enhancement dynamics with three different doses of contrast agent.
Saracco A; Szabó BK; Aspelin P; Leifland K; Tánczos E; Wilczek B; Axelsson R
Acta Radiol; 2015 Jan; 56(1):34-41. PubMed ID: 24445092
[TBL] [Abstract][Full Text] [Related]
45. Perfusion curve f (t) analysis of breast cancer by contrast-enhanced ultrasonography.
Guo L; Liu ZG; Han PH; Yuan Q; He Y; Li J
Acta Radiol; 2012 Nov; 53(9):981-6. PubMed ID: 22969089
[TBL] [Abstract][Full Text] [Related]
46. Clinical value and application of contrast-enhanced ultrasound in the differential diagnosis of malignant and benign breast lesions.
Zhang Y; Zhang B; Fan X; Mao D
Exp Ther Med; 2020 Sep; 20(3):2063-2069. PubMed ID: 32782518
[TBL] [Abstract][Full Text] [Related]
47. Dynamic contrast-enhanced ultrasound parametric maps to evaluate intratumoral vascularization.
Pitre-Champagnat S; Leguerney I; Bosq J; Peronneau P; Kiessling F; Calmels L; Coulot J; Lassau N
Invest Radiol; 2015 Apr; 50(4):212-7. PubMed ID: 25275834
[TBL] [Abstract][Full Text] [Related]
48. Perfusion characteristics of parotid gland tumors evaluated by contrast-enhanced ultrasound.
Klotz LV; Gürkov R; Eichhorn ME; Siedek V; Krause E; Jauch KW; Reiser MF; Clevert DA
Eur J Radiol; 2013 Dec; 82(12):2227-32. PubMed ID: 24029161
[TBL] [Abstract][Full Text] [Related]
49. Differential diagnosis of focal nodular hyperplasia with quantitative parametric analysis in contrast-enhanced sonography.
Huang-Wei C; Bleuzen A; Bourlier P; Roumy J; Bouakaz A; Pourcelot L; Tranquart F
Invest Radiol; 2006 Mar; 41(3):363-8. PubMed ID: 16481921
[TBL] [Abstract][Full Text] [Related]
50. Contrast-Enhanced Ultrasound for Early Prediction of Response of Breast Cancer to Neoadjuvant Chemotherapy.
Lee YJ; Kim SH; Kang BJ; Kim YJ
Ultraschall Med; 2019 Apr; 40(2):194-204. PubMed ID: 30103213
[TBL] [Abstract][Full Text] [Related]
51. Diagnostic value of contrast-enhanced ultrasound parametric imaging in breast tumors.
Yuan Z; Quan J; Yunxiao Z; Jian C; Zhu H; Liping G
J Breast Cancer; 2013 Jun; 16(2):208-13. PubMed ID: 23843855
[TBL] [Abstract][Full Text] [Related]
52. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
53. Comparison of diagnostic performance of unenhanced vs SonoVue - enhanced ultrasonography in focal liver lesions characterization. The experience of three Italian centers.
Quaia E; Stacul F; Gaiani S; Ricci P; Passariello R; Curzio D; Pozzi Mucelli R
Radiol Med; 2004; 108(1-2):71-81. PubMed ID: 15269691
[TBL] [Abstract][Full Text] [Related]
54. Quantitative contrast-enhanced ultrasonography for the differential diagnosis of endometrial hyperplasia and endometrial neoplasms.
Liu Y; Xu Y; Cheng W; Liu X
Oncol Lett; 2016 Nov; 12(5):3763-3770. PubMed ID: 27895728
[TBL] [Abstract][Full Text] [Related]
55. Characterization of focal liver lesions with contrast-enhanced ultrasound.
Piscaglia F; Lencioni R; Sagrini E; Pina CD; Cioni D; Vidili G; Bolondi L
Ultrasound Med Biol; 2010 Apr; 36(4):531-50. PubMed ID: 20350680
[TBL] [Abstract][Full Text] [Related]
56. [Characteristics of renal occupying lesions in contrast-enhanced ultrasonography].
Zhang S; Lin L; Li JH; Qiu L; Han P
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Nov; 45(6):984-7. PubMed ID: 25571729
[TBL] [Abstract][Full Text] [Related]
57. Assessment of renal quality with quantitative contrast-enhanced ultrasound (CEUS) for differentiating kidney histopathology before procurement.
Dong S; Zhang B; Chen Z; Du D; Shi H; Zhao Y; Tang Y; Luo H; Jiang J
Int J Med Sci; 2024; 21(1):19-26. PubMed ID: 38164356
[No Abstract] [Full Text] [Related]
58. [Heterogeneity of angioarchitecture and their hemodynamic changes in benign and malignant breast tumors].
Li YJ; Wen G; Yang L; Zhang XL
Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):24-7. PubMed ID: 19538864
[TBL] [Abstract][Full Text] [Related]
59. Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors.
Rennert J; Georgieva M; Schreyer AG; Jung W; Ross C; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2011; 49(1-4):67-81. PubMed ID: 22214679
[TBL] [Abstract][Full Text] [Related]
60. Contrast-Enhanced Ultrasound in Distinguishing between Malignant and Benign Peripheral Pulmonary Consolidations: The Debated Utility of the Contrast Enhancement Arrival Time.
Quarato CMI; Feragalli B; Lacedonia D; Rea G; Scioscia G; Maiello E; Di Micco C; Borelli C; Mirijello A; Graziano P; Dimitri L; Villani R; Sperandeo M
Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832153
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
